Veracyte Inc (VCYT)
35.72
+0.08%
Veracyte Inc (VCYT) is currently trading at $35.72. This represents a gain of 0.08% from the previous session. With a market capitalization of $2.84B, VCYT is a key component of the Health Care sector. Investors looking to trade VCYT should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade VCYT commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Veracyte Inc (VCYT) shows a bullish trend. Analysts are watching the 36.66 level closely.
Fundamentals
Mkt Cap2.84B
P/E Ratio0.0000
Volume662,897
60-Day Technical Chart
Advanced Charting
Need more indicators for VCYT? Use the world's #1 platform.
Open VCYT on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $36
| Metric |
VCYT +0.08% |
SMCI +7.87% |
IONQ +6.23% |
CMG +2.82% |
|---|---|---|---|---|
| Price | $35.72 | $33.60 | $33.59 | $37.50 |
| Mkt Cap | $2.84B | $20.22B | $12.07B | $48.80B |
| - | View → | View → | View → |
Latest Headlines
Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 33% Potential Upside in Diagnostics Innovation
DirectorsTalk Interviews • Feb 25, 2026
Does Veracyte (VCYT) Offer Both Strength and Opportunity?
Yahoo Finance • Feb 23, 2026
Veracyte Inc (NASDAQ:VCYT): A Prime GARP Stock with Strong Growth and a Sound Balance Sheet
ChartMill • Feb 21, 2026
Bladder and prostate cancer care get genomic focus in Veracyte’s ASCO GU data
Stock Titan • Feb 24, 2026
Here's How Veracyte Stock Is Placed Ahead of Q4 Earnings
TradingView • Feb 16, 2026
● Gemini Agentic AI Analyst Insight for VCYT
Market Education
- Large Cap at Lowest Price Apr 9, 2024
- Santa Rally: What It Is and How It Affects the Stock Market Dec 10, 2024
- Exploring Gann Trading: An Insightful Guide for Traders Jun 2, 2024
External Research